These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6323711)

  • 1. Mixed lymphocyte reaction in gestational trophoblastic disease: presence of a specific plasma inhibitor of the response to paternal alloantigens.
    Ho PC; Wong LC; Lawton JW; Ma HK
    J Reprod Immunol; 1984 Feb; 6(2):105-10. PubMed ID: 6323711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mixed lymphocyte reaction in hydatidiform mole.
    Ho PC; Wong LC; Lawton JW; Ma HK
    Am J Reprod Immunol (1980); 1984; 6(1):25-7. PubMed ID: 6236700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific inhibitory substance to the husband's HLA allotype in sera from patients with gestational trophoblastic disease detected by lymphocytotoxicity testing.
    Kato S; Tsuji K; Furuhashi Y; Goto S; Saito M; Tomoda Y
    Am J Reprod Immunol; 1989 Aug; 20(4):126-34. PubMed ID: 2560376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy outcome in human couples with recurrent spontaneous abortions: HLA antigen profiles; HLA antigen sharing; female serum MLR blocking factors; and paternal leukocyte immunization.
    Beer AE; Semprini AE; Zhu XY; Quebbeman JF
    Exp Clin Immunogenet; 1985; 2(3):137-53. PubMed ID: 2978830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral and cellular immunity to paternal antigens in trophoblastic neoplasia.
    Shaw AR; Dasgupta MK; Kovithavongs T; Johny KV; leRiche JC; Dossetor JB; McPherson TA
    Int J Cancer; 1979 Nov; 24(5):586-93. PubMed ID: 231016
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on antilymphocyte antibodies in gestational choriocarcinoma.
    Kanazawa K; Kajino T; Takeuchi S
    Hum Reprod; 1986 Dec; 1(8):519-22. PubMed ID: 2950130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic studies in patients with trophoblastic neoplasia.
    Tomoda Y; Fuma M; Saiki N; Ishizuka N; Akaza T
    Am J Obstet Gynecol; 1976 Nov; 126(6):661-7. PubMed ID: 185908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further studies on immunological parameters in gestational trophoblastic neoplasia.
    Ho PC; Wong LC; Lawton JW; Ma HK
    Arch Gynecol; 1984; 234(4):255-61. PubMed ID: 6089673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological parameters in gestational trophoblastic neoplasia.
    Ho PC; Mak LW; Lawton JW; Ma HK
    J Reprod Immunol; 1980 Feb; 1(5-6):307-19. PubMed ID: 6251216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunology of gestational trophoblastic neoplasms.
    Pattillo RA
    Semin Oncol; 1982 Jun; 9(2):157-62. PubMed ID: 6289459
    [No Abstract]   [Full Text] [Related]  

  • 11. [The c-erbB-related oncoproteins in normal placenta and in gestational trophoblastic diseases (in vitro study)].
    Fülöp V; Végh G; Doszpod J
    Orv Hetil; 2001 Jun; 142(22):1147-54. PubMed ID: 11424588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relation between malignant trophoblastic disease and factor VII related antigen (VIII R:AG)].
    Liu EZ
    Zhonghua Fu Chan Ke Za Zhi; 1983 Jan; 18(1):38-9, 62. PubMed ID: 6303718
    [No Abstract]   [Full Text] [Related]  

  • 13. T-cell subsets and natural killer cell activity in patients with gestational trophoblastic neoplasia.
    Ho PC; Lawton JW; Wong LC; Ma HK
    Am J Obstet Gynecol; 1986 Aug; 155(2):330-4. PubMed ID: 3017112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA antigens in husband-wife pairs with trophoblastic tumor.
    Yamashita K; Ishikawa M; Shimizu T; Kuroda M
    Gynecol Oncol; 1981 Aug; 12(1):68-74. PubMed ID: 6168517
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on some trace elements and cell-mediated immunity in patients with gestational trophoblastic disease.
    Wang CY; Qi XM
    J Tongji Med Univ; 1993; 13(1):51-5. PubMed ID: 8392112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MLR-blocking antibodies are directed against alloantigens expressed on syncytiotrophoblasts.
    Goto S; Takakuwa K; Kanazawa K; Takeuchi S
    Am J Reprod Immunol; 1989 Oct; 21(2):50-3. PubMed ID: 2534038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical studies on cell-mediated immunity in gestational trophoblastic disease: nonspecific cellular immunocompetence in patients with hydatid mole and trophoblastic neoplasia.
    Sasaki T; Fujisaki S
    Microbiol Immunol; 1981; 25(4):387-401. PubMed ID: 6265741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mixed lymphocyte reaction blocking factors (MLR-Bf) as potential biomarker for indication and efficacy of paternal lymphocyte immunization in recurrent spontaneous abortion.
    Khonina NA; Broitman EV; Shevela EY; Pasman NM; Chernykh ER
    Arch Gynecol Obstet; 2013 Oct; 288(4):933-7. PubMed ID: 23558562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4+ CD25+ regulatory T cells in human pregnancy: development of a Treg-MLC-ELISPOT suppression assay and indications of paternal specific Tregs.
    Mjösberg J; Berg G; Ernerudh J; Ekerfelt C
    Immunology; 2007 Apr; 120(4):456-66. PubMed ID: 17229266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunological and hormono-metabolic indices in trophoblastic disease].
    Poroshina TE; Semenovskiĭ AV; Bobrov IuF; Gamaiunova VB; Ostroumova MN
    Vopr Onkol; 1987; 33(10):57-61. PubMed ID: 2825428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.